Martingale Asset Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Buy
125,693
+18,545
+17% +$399K 0.07% 265
2025
Q4
$2.14M Buy
107,148
+27,734
+35% +$542K 0.05% 302
2025
Q3
$1.45M Buy
79,414
+101
+0.1% +$1.97K 0.04% 401
2025
Q2
$1.59M Buy
79,313
+901
+1% +$17.3K 0.04% 353
2025
Q1
$1.42M Buy
78,412
+570
+0.7% +$10.2K 0.04% 379
2024
Q4
$1.35M Hold
77,842
0.03% 406
2024
Q3
$1.5M Buy
77,842
+550
+0.7% +$10.1K 0.03% 379
2024
Q2
$1.27M Hold
77,292
0.03% 398
2024
Q1
$1.18M Buy
77,292
+1,400
+2% +$22K 0.02% 432
2023
Q4
$1.22M Hold
75,892
0.02% 405
2023
Q3
$986K Sell
75,892
-47
-0.1% -$610 0.02% 439
2023
Q2
$967K Buy
75,939
+2,001
+3% +$25K 0.02% 459
2023
Q1
$832K Buy
73,938
+2,822
+4% +$34.2K 0.02% 493
2022
Q4
$942K Buy
71,116
+2,057
+3% +$27K 0.02% 473
2022
Q3
$803K Sell
69,059
-26,120
-27% -$358K 0.02% 498
2022
Q2
$1.41M Sell
95,179
-14
-0% -$229 0.03% 369
2022
Q1
$1.84M Buy
95,193
+26,552
+39% +$474K 0.03% 316
2021
Q4
$1.19M Buy
68,641
+15,092
+28% +$257K 0.02% 452
2021
Q3
$895K Buy
53,549
+41,600
+348% +$622K 0.01% 534
2021
Q2
$161K Buy
+11,949
New +$150K ﹤0.01% 814
2021
Q1
Sell
-23,149
Closed -$287K 873
2020
Q4
$287K Sell
23,149
-43,500
-65% -$469K ﹤0.01% 753
2020
Q3
$697K Sell
66,649
-56,500
-46% -$718K 0.01% 726
2020
Q2
$1.72M Sell
123,149
-6
-0% -$82 0.02% 580
2020
Q1
$1.45M Buy
+123,155
New +$1.63M 0.02% 568
2019
Q1
Sell
-42,850
Closed -$748K 1033
2018
Q4
$748K Buy
+42,850
New +$696K 0.01% 798
2016
Q1
Sell
-18,000
Closed -$190K 833
2015
Q4
$190K Sell
18,000
-600
-3% -$5.52K ﹤0.01% 801
2015
Q3
$134K Buy
18,600
+1,598
+9% +$21.7K ﹤0.01% 817
2015
Q2
$308K Buy
17,002
+6,902
+68% +$119K 0.01% 771
2015
Q1
$159K Buy
+10,100
New +$153K ﹤0.01% 849

Other funds holding INVA

Martingale Asset Management's INVA Position: Q1 2026 in Review

Martingale Asset Management increased its Innoviva (INVA) stake by 17% in Q1 2026, buying an estimated $399K and bringing the position to 125,693 shares worth $2.93M. The position accounts for 0.07% of the portfolio, ranked #265.

Martingale Asset Management first reported a position in INVA in Q1 2015 and has held it in 29 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Martingale Asset Management held 125,693 shares of Innoviva worth $2.93M as of Q1 2026.
  • Martingale Asset Management bought 18,545 Innoviva shares in Q1 2026, an estimated $399K.
  • Innoviva made up 0.07% of Martingale Asset Management's portfolio in Q1 2026, its #265 holding.
  • Martingale Asset Management first reported a position in Innoviva in Q1 2015 and has held it in 29 quarters since.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.